Intravenous gamma-globulin in the treatment of neonatal sepsis with special reference to group B streptococci and pharmacokinetics.
D000818:Animals; D000907:Antibodies, Bacterial / Q000378:metabolism / Q000627:therapeutic use*; D000918:Antibody Specificity; D001426:Bacterial Proteins / Q000276:immunology; D004195:Disease Models, Animal; D006801:Humans; D007116:Immunization, Passive; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000378:metabolism; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000628:therapy*; D007275:Injections, Intravenous; D051379:Mice; D011135:Polysaccharides, Bacterial / Q000276:immunology; D018805:Sepsis / Q000628:therapy*; D013290:Streptococcal Infections / Q000628:therapy*; D013292:Streptococcus agalactiae / Q000276:immunology
D000907:Antibodies, Bacterial; D001426:Bacterial Proteins; D007074:Immunoglobulin G; D011135:Polysaccharides, Bacterial